1. Home
  2. PSNL vs BLKB Comparison

PSNL vs BLKB Comparison

Compare PSNL & BLKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Personalis Inc.

PSNL

Personalis Inc.

SELL

Current Price

$15.65

Market Cap

1.7B

Sector

Health Care

ML Signal

SELL

Logo Blackbaud Inc.

BLKB

Blackbaud Inc.

SELL

Current Price

$51.73

Market Cap

1.5B

Sector

Technology

ML Signal

SELL

Company Overview

Basic Information
Metric
PSNL
BLKB
Founded
2011
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
2019
2004

Fundamental Metrics

Financial Performance
Metric
PSNL
BLKB
Price
$15.65
$51.73
Analyst Decision
Hold
Buy
Analyst Count
5
4
Target Price
$15.17
★ $51.50
AVG Volume (30 Days)
★ 2.1M
411.4K
Earning Date
11-03-2026
10-28-2026
Dividend Yield
N/A
N/A
EPS Growth
33.58
★ 142.32
EPS
N/A
★ 1.46
Revenue
★ $69,648,000.00
N/A
Revenue This Year
$21.10
$4.34
Revenue Next Year
$30.66
$4.64
P/E Ratio
★ N/A
$35.21
Revenue Growth
N/A
★ N/A
52 Week Low
$4.96
$25.58
52 Week High
$18.89
$70.71

Technical Indicators

Market Signals
Indicator
PSNL
BLKB
Relative Strength Index (RSI) 40.41 76.48
Support Level $13.68 $45.83
Resistance Level $16.58 $53.25
Average True Range (ATR) 0.35 1.53
MACD -0.09 0.96
Stochastic Oscillator 10.70 94.02

Price Performance

Historical Comparison
PSNL
BLKB

About PSNL Personalis Inc.

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

About BLKB Blackbaud Inc.

Founded in 1981, Blackbaud provides software solutions designed to serve the "social good" community, including nonprofits, foundations, corporations, educational institutions, healthcare institutions, and individual change agents. Through M&A and organic product development efforts, the company has also moved into related areas outside core fundraising, notably into K-12 schools. The firm enables more than $100 billion in donations annually across a customer base in excess of 40,000 customers in over 100 countries.

Share on Social Networks: